Linagliptin CAS:668270-12-0 Manufacturer Supplier

Linagliptin (mazita ekutengeserana Tradjenta uye Trajetna) inhibitor yedipeptidyl peptidase-4 (DPP-4) iyo yakatenderwa neUS FDA muna Chivabvu 2011 pakurapa Type 2 chirwere cheshuga pamwe nekudya uye maekisesaizi.Linagliptin (BI-1356) yakatsanangurwa seyakanyanya kusarudza, inononoka-kunonoka chiyero uye yakareba ichiita inhibitor yeDPP-4.Linagliptin yakasimuka kubva mukugadzirisa kuedza kwe xanthine-based DPP-4 inhibitors ine yekutanga inotungamira yakaonekwa kubva kumushandirapamwe weHTS.

Order kana Kumbira Quote

Product Detail

Product Tags

Application uye Effect

Linagliptin (TrajentaR, Tradjenta TM, Trazenta TM, Trayenta TM) inhibitor yemuromo, yakasarudzwa zvikuru ye dipeptidyl peptidase-4 uye ndiyo yekutanga mumiriri wekirasi yayo kubviswa zvakanyanya kuburikidza nenzira isiri renal.Linagliptin inoratidzwa kuti ishandiswe kamwe chete pazuva pakurapa kwevakuru vane chirwere cheshuga mellitus. Linagliptin inoshanda kudzikisa mazinga eglucose muropa nekuvharira iyo enzyme DPP-4, nekudaro ichidzivirira kuderera kweiyo incretin mahomoni (glucagon-like peptide-1 [GLP). -1] uye glucose-inotsamira insulinotropic peptide) uye attenuating postprandial glucose excursions.

Product Sample

Product Packing:

Ruzivo Rwokuwedzera:

Composition	C25H28N8O2
Assay	99%
Chitarisiko	Upfu chena
CAS Nha.	668270-12-0
Packing	25KG
Sherufu Hupenyu	2 years
Storage	Chengetedza munzvimbo inotonhorera uye yakaoma
Certification	ISO.